Analyst Price Targets — MSLE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 9, 2026 10:47 am | — | Wells Fargo | $18.00 | $8.98 | StreetInsider | Satellos Bioscience Inc. (MSLE) PT Raised to $18 at H.C. Wainwright |
| July 9, 2026 10:06 am | — | H.C. Wainwright | $18.00 | $8.98 | TheFly | Satellos price target raised to $18 from $11 at H.C. Wainwright |
| April 28, 2026 10:40 am | — | Guggenheim | $23.00 | $7.16 | TheFly | Satellos initiated with a Buy at Guggenheim |
Latest News for MSLE
Recently listed, Satellos Bioscience Inc. (NASDAQ:MSLE) on Wednesday reported six-month interim data from its ongoing TRAILHEAD study of SAT-3247 for Duchenne muscular dystrophy (DMD)
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, announced today the results of its Annual Meeting of Shareholders held June 17, 2026 (the "Meeting").
TORONTO, May 27, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that members of the Company management team will participate in the following investor conferences in June.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for MSLE.
Senate Trading
No Senate trades found for MSLE.
U.S. House Trading
No House trades found for MSLE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.